EyeYon Medical’s core products include the EndoArt® which is an artificial endothelial implant that can replace the human donor corneal endothelial and the Hyper CL which is a therapeutic contact lens for treating corneal edema, with drug delivery feature.

BELKIN Laser presents a unique non-contact automatic one-second SLT device, aimed at treating all different kinds of glaucoma, including POAG and PACG, to become the first-line choice for glaucoma therapy for every patient, all over the world.

The company focuses on innovative technology in presbyopic glasses.

6 Over 6 Vision is developing a suite of smartphone based pure-software online solution such as refractor, lens meter, PD meter and visual acuity testing, aiming to provide more people with online precision optical services anywhere

 

EyeControl has developed a set of intuitive eye gestures assistive communication devices, for ICU patients, ALS patients and others with locked-in syndrome, allowing them to communicate with doctors, nurses and family members through an intelligent communication system controlled by their eyes movements

 

Eximore is innovative company of ophthalmic drug delivery platform. It's developed a non-invasive eye delivery platform based on unique materials, It also can control the drugs to be released slowly and persistently in ocular surface, greatly improve the drug effect time and solve the compliance problem of using the eye drops.

Based on eye-tracking, propriety active glasses and other technologies, the company has developed a series of automated software and hardware products for amblyopia and strabismus screening, diagnosis and rehabilitation training, which can highly improve the diagnostic accuracy and treatment success of amblyopia and strabismus in children

Pykus Therapeutics, Inc. was founded in 2016 to develop a novel hydrogel to replace the use of intraocular gas during retinal surgery to make retinal surgery less painful and more successful.

The company is developing a small molecule drug to block formation of Aβ oligomers, the origin of Aβ protein toxicity, and reduce its damage to nerve cell. First time through the optic nerve level, we can treat glaucoma ($4Bn market), dry AMD (over 200mm patients and currently no treatment options) and Alzheimer's disease (optional).

Eyeyon has developed a therapeutic contact lens platform for chronic corneal edema and other corneal-related disorders and post-operative procedures. Eyeyon is also developing a synthetic fluid barrier that has the potential to displace a difficult cadaver based corneal endothelial transplantation procedure, with a simple, easy to implant off the shelf synthetic product.

BELKIN Laser presents a unique one-second glaucoma laser treatment, aimed at revolutionizing access to glaucoma care by becoming the first-line choice for glaucoma therapy for every patient, all over the world.

The company is mainly focused on the innovation technology in progressive lens sector

6over6 Vision provides a mobile platform utilizing complete and accurate measurements of the refractive error of the eye for Myopia, Astigmatism and Hyperopia, alongside with a toolbox of Lensmeter and Pupilmeter (PD), to deliver all the essential vision care services directly to the hands of the users, in an accurate, user friendly, purely software solution APP

EyeControl is a wearable device that tracks the movement of the pupil and transmit it to the CPU of the device or to other devices (Smart phones, tablets etc.) in order to create communication or any other actions. it mainly support the patients in ICU or locked-in patients (eg ALS). 

Eximore is developing ophthalmic drug delivery products. The company’s initial target development is a non-invasive punctal plug designed to release glaucoma drugs, controlled over a long period of time.ximore’s product will relieve the patients from the need to apply daily eye drops and will solve the compliance problem.

The company is developing a series of new product based eye tracking technology to screen, diagnose and therapy of strabismus and amblyopia

6over6 Vision provides a mobile platform utilizing complete and accurate measurements of the refractive error of the eye for Myopia, Astigmatism and Hyperopia, alongside with a toolbox of Lensmeter and Pupilmeter (PD), to deliver all the essential vision care services directly to the hands of the users, in an accurate, user friendly, purely software solution APP

6over6 Vision provides a mobile platform utilizing complete and accurate measurements of the refractive error of the eye for Myopia, Astigmatism and Hyperopia, alongside with a toolbox of Lensmeter and Pupilmeter (PD), to deliver all the essential vision care services directly to the hands of the users, in an accurate, user friendly, purely software solution APP

6over6 Vision provides a mobile platform utilizing complete and accurate measurements of the refractive error of the eye for Myopia, Astigmatism and Hyperopia, alongside with a toolbox of Lensmeter and Pupilmeter (PD), to deliver all the essential vision care services directly to the hands of the users, in an accurate, user friendly, purely software solution APP

6over6 Vision provides a mobile platform utilizing complete and accurate measurements of the refractive error of the eye for Myopia, Astigmatism and Hyperopia, alongside with a toolbox of Lensmeter and Pupilmeter (PD), to deliver all the essential vision care services directly to the hands of the users, in an accurate, user friendly, purely software solution APP

6over6 Vision provides a mobile platform utilizing complete and accurate measurements of the refractive error of the eye for Myopia, Astigmatism and Hyperopia, alongside with a toolbox of Lensmeter and Pupilmeter (PD), to deliver all the essential vision care services directly to the hands of the users, in an accurate, user friendly, purely software solution APP

PORTOFLIO,Rimonci睿盟希资本,

PORTOFLIO-Rimonci睿盟希资本

PORTOFLIO,Rimonci睿盟希资本